HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Today, Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) announced that it has entered into an exclusive licensing agreement with ArriVent BioPharma, Inc. for ...

Lepu Biopharma Co. Ltd. Class H ( (HK:2157)) has shared an update. Lepu Biopharma has confirmed that all conditions precedent under its Share Purchase Agreement with Excalipoint have been satisfied ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

SUZHOU, China, Nov. 21, 2025 /PRNewswire/ -- On November 20, 2025, BioDlink (Stock Code: 1875.HK), a leading biologics CDMO, together with Lepu Biopharma (2157.HK), announced the successful market ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Lepu Biopharma Co., Ltd. announces ...

This partnership has effectively integrated DP's ADC Linker-Payload design platform with Lepu's ADC technology development platform, capitalizing on their respective strengths. The overall ...

A new Caribbean company has emerged to enter the increasingly crowded T-cell engager space. Excalipoint, incorporated in the Cayman Islands, is paying $10 million upfront to China’s Lepu Biopharma in ...

After taking its Lepu Biopharma unit public in February, Lepu Medical is pressing ahead with a third attempt at listing is Lepu ScienTech unit in Hong Kong China’s healthcare regulator has said it won ...

Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update. Lepu Biopharma Co. Ltd. announces the successful completion of its new H Shares placement, raising approximately HK$234.36 million in ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...